Cell Surface Glycoprotein CD200 Receptor 1 (CD200R1) Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-Cell Surface Glycoprotein CD200 Receptor 1 (CD200R1) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCell Surface Glycoprotein CD200 Receptor 1 (CD200R1)
Clonemonoclonal
Host SpeciesMouse
Reactive Specieshuman
IsotypeIgG1 kappa
FormatProtein A purified
Size0.1 mg,
Concentration1 mg/ml
ApplicationsIF/ICC, FCM
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionCell Surface Glycoprotein CD200 Receptor 1 (CD200R1) antibody is a mouse monoclonal antibody against Cell Surface Glycoprotein CD200 Receptor 1 (CD200R1). This gene encodes a receptor for the OX-2 membrane glycoprotein. Both the receptor and substrate are cell surface glycoproteins containing two immunoglobulin-like domains. This receptor is restricted to the surfaces of myeloid lineage cells and the receptor-substrate interaction may function as a myeloid downregulatory signal. Mouse studies of a related gene suggest that this interaction may control myeloid function in a tissue-specific manner. Alternative splicing of this gene results in multiple transcript variants.
ImmunogenRecombinant human CD200R.
Other Namesn/a
Gene, Accession #Gene ID: 131450, UniProt: Q8TD46
Catalog #abx347151
Priceplease inquire
Order / More InfoCell Surface Glycoprotein CD200 Receptor 1 (CD200R1) Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.